Trial Profile
Phase I clinical trial of an inhibitor of proto-oncogene protein b-raf.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 16 Nov 2011
Price :
$35
*
At a glance
- Drugs Proto oncogene protein b raf inhibitors
- Indications Cancer
- Focus Adverse reactions
- 16 Nov 2011 New trial record